🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Turkey / NCT07786753
Starting soon Observational

Impact of Intraoperative Perfusion Variability on Postoperative Troponin Elevation in Geriatric Patients Undergoing Major Oncologic Surgery

NCT07786753 · tracked via the Priya Life Science Turkey tracker
Phase
Observational
Started
2026-09-01
Last updated
2026-09-16

Condition(s) studied

Postoperative Troponin ElevationIntraoperative Perfusion

Study summary

This prospective observational study aims to evaluate the association between intraoperative perfusion variability and postoperative troponin elevation in geriatric patients undergoing major oncologic surgery. Intraoperative hemodynamic and perfusion-related parameters will be recorded, and postoperative troponin levels will be assessed to investigate whether intraoperative perfusion changes are associated with myocardial injury. Troponin measurements will be obtained preoperatively and at 24 hours after surgery

Eligibility

Sex
ALL
Min age
65 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Age 65 years or older * Undergoing major abdominal oncologic surgery * Availability of preoperative and 24-hour postoperative troponin measurements * Complete intraoperative and postoperative patient monitoring records * Provision of written informed consent Exclusion Criteria: * Age younger than 65 years * Absence of preoperative or 24-hour postoperative troponin measurements * Incomplete intraoperative or postoperative patient monitoring records * Undergoing emergency surgery * Advanced heart failure * ASA Physical Status IV * Pulmonary artery pressure \>40 mmHg

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Ankara Dr. Abdurrahman Yurtaslan Oncolgy Training and Research Hospital Yenimahalle Ankara

More Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital trials in Turkey

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07786753 on ClinicalTrials.gov ↗ ← All trials in Turkey